 | Up a level |
Cassese, Salvatore; Byrne, Robert A; Jüni, Peter; Wykrzykowska, Joanna J; Puricel, Serban; Ndrepepa, Gjin; Schunkert, Heribert; Fusaro, Massimiliano; Cook, Stephane; Kimura, Takeshi; Henriques, Jose P S; Serruys, Patrick W; Windecker, Stephan; Kastrati, Adnan (2018). Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials. EuroIntervention, 13(13), pp. 1565-1573. Europa Digital & Publishing 10.4244/EIJ-D-17-00492
Xhepa, Erion; Tada, Tomohisa; Kufner, Sebastian; Ndrepepa, Gjin; Byrne, Robert A; Kreutzer, Johanna; Ibrahim, Tareq; Tiroch, Klaus; Valgimigli, Marco; Tölg, Ralf; Cassese, Salvatore; Fusaro, Massimiliano; Schunkert, Heribert; Laugwitz, Karl L; Mehilli, Julinda; Kastrati, Adnan (2017). Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials. Catheterization and cardiovascular interventions, 89(1), pp. 1-10. Wiley-Blackwell 10.1002/ccd.26645
Cassese, Salvatore; Kufner, Sebastian; Xhepa, Erion; Byrne, Robert A; Kreutzer, Johanna; Ibrahim, Tareq; Tiroch, Klaus; Valgimigli, Marco; Tölg, Ralph; Fusaro, Massimiliano; Schunkert, Heribert; Laugwitz, Karl-Ludwig; Mehilli, Julinda; Kastrati, Adnan (2016). Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials. Clinical research in cardiology, 105(7), pp. 575-584. Springer-Medizin-Verlag 10.1007/s00392-015-0953-x
